Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03748134
Title Sintilimab or Placebo With Chemotherapy in Esophageal Squamous Cell Carcinoma (ORIENT-15)
Recruitment Completed
Gender both
Phase Phase III
Variant Requirements No
Sponsors Innovent Biologics (Suzhou) Co. Ltd.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | FRA | ESP | BEL | AUS


No variant requirements are available.